Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Other Non-Current Liabilities (2016 - 2025)

Fresenius Medical Care AG has reported Other Non-Current Liabilities over the past 17 years, most recently at $585.6 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $585.6 million for Q4 2025, down 39.97% from a year ago — trailing twelve months through Dec 2025 was $585.6 million (down 39.97% YoY), and the annual figure for FY2025 was $585.6 million, down 39.97%.
  • Other Non-Current Liabilities for Q4 2025 was $585.6 million at Fresenius Medical Care AG, down from $975.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for FMCQF hit a ceiling of $1.2 billion in Q4 2022 and a floor of $585.6 million in Q4 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $975.5 million (2024), compared with a mean of $941.3 million.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 49.23% in 2022 and later plummeted 39.97% in 2025.
  • Fresenius Medical Care AG's Other Non-Current Liabilities stood at $809.4 million in 2021, then surged by 49.23% to $1.2 billion in 2022, then dropped by 6.61% to $1.1 billion in 2023, then dropped by 13.53% to $975.5 million in 2024, then plummeted by 39.97% to $585.6 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $585.6 million (Q4 2025), $975.5 million (Q4 2024), and $1.1 billion (Q4 2023) per Business Quant data.